相关实验视频

Updated: Jun 11, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

通过泛NRAS单体抑制和降解NRAS

Michael Whaby^1,2, Gayatri Ketavarapu³, Akiko Koide^3,4

¹Department of Cell and Molecular Pharmacology & Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.

|October 8, 2024

概括

研究人员开发了一种新型单体,针对NRAS GTPases,这对于黑色素瘤等癌症至关重要. 这种NRAS抑制剂不论突变类型如何起作用,可以被设计为降解剂,解决癌症治疗中的重大未满足需求.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药物发现药物发现药物发现

背景情况:

RAS家族GTPases是人类癌症中经常发生突变的瘤基因,NRAS突变在黑色素瘤中很常见.
激活NRAS突变驱动瘤生长,目前缺乏有效的NRAS特定疗法.
黑色素瘤中对BRAF抑制剂的耐药性通常涉及NRAS突变,突出了对NRAS向治疗的需求.

研究的目的:

开发针对NRAS GTPases的新型抑制剂.
创建一种治疗药物,以一种不依赖于突变的方式,对NRAS突变有效.
探索NRAS抑制剂在克服对现有癌症疗法的耐药性的潜力.

主要方法:

通过蛋白质工程开发一种新的单体.
对NRAS的GDP和GTP绑定状态都具有约束力的单体的表征.
评估单体对NRAS介导的信号抑制.
将单体设计成一个基因编码的NRAS特异性降解剂.

主要成果:

成功开发了一种单体,在GDP和GTP绑定的状态中特别与NRAS结合.
单体有效地抑制NRAS介导的信号传递,以一种突变不可知的方式.
单体可以被格式化为基因编码的NRAS特异性降解剂,证明了治疗潜力.

结论:

这项研究证明了开发NRAS选择性抑制剂的可行性.
这种新型单体代表了对具有NRAS突变的癌症有前途的治疗策略.
这项工作解决了在瘤学中对NRAS向药理学药物的关键未满足需求.

更多相关视频

Inducible and Reversible Dominant-negative DN Protein Inhibition

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...